- Who can participate: Adults aged 18 to 65 who have been diagnosed with chronic migraines and have experienced at least 15 headache days per month for the past three months are eligible to participate. Participants must not have any other significant health issues that could interfere with the study.
- Study details: Participants will attend regular clinic visits where they will receive the investigational treatment or placebo. They will be required to maintain a headache diary and report any side effects. The study will include assessments of headache frequency, severity, and impact on daily activities.

